New research suggests that an increased risk of chronic kidney disease may be among the many Actos side effects. A recent study published in medical journal PLoS One suggests that the diabetes drug may be linked to chronic kidney disease. The study was conducted by... Read More

A Lafayette, Louisiana jury has ordered Takeda Pharmaceutical Co. and Eli Lilly Co. to pay a combined total of $9 billion in compensation for Actos side effects. While Takeda was ordered to pay $6 billion and their partner Eli Lilly was ordered to pay $3... Read More

The outcome of the latest Actos bladder cancer trial is drawing the attention of attorneys and advocates from both sides for two main reasons. The plaintiffs' attorney is asking for a multi-billion dollar punitive damages verdict, which would be the largest jury award in Nevada... Read More

The opening witness in the first “bellwether” Actos cancer trial told the jury about drug manufacturer Takeda’s pretrial misconduct.  The case is the first of several scheduled in the ongoing Actos Multidistrict Litigation (MDL) in federal court in Louisiana. Terrence Allen and his wife’s lawsuit... Read More

The rambling, sometimes comical list of drug side effects in TV commercials may soon be a thing of the past, as the FDA begins a new study to determine the impact of such direct-to-consumer ads. Health regulators are concerned that the list, which often names... Read More

Just one week before opening statements in the bellwether trial for the federal MDL (multidistrict litigation) involving nearly 3000 Actos bladder cancer lawsuits, Takeda Pharmaceuticals suffered a blow regarding evidence discovery. On January 27, 2014, the federal MDL judge ruled that Takeda breached its duty... Read More

Takeda Pharmaceutical Company, the manufacturer of the controversial diabetes drug Actos that has been tied to an increased risk of bladder cancer, has abandoned its development on another type 2 diabetes medication due to its potential to cause liver damage. Takeda voluntarily stopped working on... Read More

With the outcome of thousands of lawsuits potentially at stake, the first bellwether Actos cancer trial is scheduled to begin soon in U.S. District Court for the Western District of Louisiana. This trial is expected to set the tone for future Actos litigation, as plaintiffs,... Read More